Accelerated Drug Approval Program Holds Potential for Neurology Patients, New Paper Explains

Clinical awareness paper details the program's history and debunks popular misconceptions TALLAHASSEE, Fla., March 1, 2023 /PRNewswire/ -- A new https://c212.net/c/link/?t=0&l=en&o=3797401-1&h=4177023194&u=https%3A%2F%2Fwww.neuroamerica.org%2Fwp-content%2Fuploads%2F2023%2F03%2FCNSA-Accelerated-Approval-WhitePaper-March-2023.pdf&a=white+paper from the Clinical Neurological Society of America explains how [...]